Long-term outcome after drug eluting stenting in patients with ST-segment Elevation Myocardial Infarction. Data from the REAL Registry

International Journal of Cardiology

Volumn 140, Issue 2, 2010, Pages 154-160

  Campo, Gianluca ^a   Saia, Francesco ^b   Percoco, Gianfranco ^a   Manari, Antonio ^c   Santarelli, Andrea ^d   Vignali, Luigi ^e   Varani, Elisabetta ^f   Benassi, Alberto ^g   Sangiorgio, Pietro ^e   Tarantino, Fabio ^h   Magnavacchi, Paolo ⁱ   De Palma, Rossana ^j   Guastaroba, Paolo ^j   Marzocchi, Antonio ^b  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d OSPEDALE DEGLI INFERMI   (Italy)

^e MAGGIORE HOSPITAL   (Italy)

^f SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^g HESPERIA HOSPITAL   (Italy)

^h MORGAGNI PIERANTONI HOSPITAL   (Italy)

ⁱ Nuovo Ospedale S Agostino   (Italy)

^j Agenzia Sanitaria Regionale Regione Emilia Romagna   (Italy)

more..

Author keywords

Acute myocardial infarction; Clinical outcome; Drug eluting stent; Primary percutaneous coronary intervention; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; REGISTRIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 77950338201     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.021     Document Type: Article

References (22)

1. Valgimigli M., Percoco G., Malagutti P., et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction. A randomized trial. JAMA 293 (2005) 2109-2117
2. Menichelli M., Parma A., Pucci E., et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 49 (2007) 1924-1930
3. Spaulding C., Henry P., Teiger E., et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
4. Laarman G.J., Suttorp M.J., Dirksen M.T., et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
5. Stone GW, A prospective, randomized comparison of paclitaxel-eluting TAXUS stents vs. bare metal stents during primary angioplasty in acute myocardial infarction-one year results of HORIZONS AMI. Transcatheter Cardiovascular Therapeutics 2008, Late Breaking Clinical Trials.
6. Spertus J.A., Kettelkamp R., Vance C., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006) 2803-2809
7. Percoco G., Manari A., Guastaroba P., et al. Safety and long-term efficacy of sirolimus eluting stent in ST-elevation acute myocardial infarction: the REAL (Registro REgionale AngiopLastiche Emilia-Romagna) registry. Cardiovasc Drugs Ther 20 (2006) 63-68
8. Kukreja N., Onuma Y., Garcia-Garcia H., et al. Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation. Circ Cardiovasc Intervent 1 (2008) 103-110
9. Mauri L., Silbaugh T.S., Garg P., et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 359 (2008) 1330-1342
10. Marzocchi A., Piovaccari G., Manari A., et al. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. Am J Cardiol 95 (2005) 1409-1414
11. Marzocchi A., Saia F., Piovaccari G., et al. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 115 (2007) 3181-3188
12. TIMI study group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
13. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
14. Kastrati A., Dibra A., Spaulding C., et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28 (2007) 2706-2713
15. Valgimigli M., Campo G., Arcozzi C., et al. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study. J Am Coll Cardiol 50 (2007) 138-145
16. van der Hoeven B.L., Liem S.S., Jukema J.W., et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. J Am Coll Cardiol 51 (2008) 618-626
17. Stettler C., Allemann S., Wandel S., et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 337 (2008) al1331
18. Eisenstein E.L., Anstrom K.J., Kong D.F., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
19. Campo G., Valgimigli M., Frangione A., et al. Prognostic value of serial platelet reactivity measurements on long-term clinical outcome in patients with ST-elevation myocardial infarction undergoing primary PCI. J Thromb Haemost 6 (2008) 1824-1826
20. Bonello L., Camoin-Jau L., Arques S., et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. J Am Coll Cardiol 51 (2008) 1404-1411
21. Valgimigli M., Campo G., Percoco G., et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA 299 (2008) 1788-1799
22. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150